Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
LANSOPRAZOLE
WPR Healthcare Limited
A02BC03
LANSOPRAZOLE
30 Milligram
Capsules Gastro-Resistant
Product subject to prescription which may be renewed (B)
Proton pump inhibitors
Authorised
2015-06-12
PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15 MG GASTRO-RESISTANT CAPSULES LANSOPRAZOLE 30 MG GASTRO-RESISTANT CAPSULES LANSOPRAZOLE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. What is in this leaflet: 1. What Lansoprazole is and what it is used for 2. What you need to know before you take Lansoprazole 3. How to take Lansoprazole 4. Possible side effects 5. How to store Lansoprazole 6. Contents of the pack and other information 1. WHAT LANSOPRAZOLE IS AND WHAT IT IS USED FOR The active ingredient in your medicine is lansoprazole, which is a proton pump inhibitor. Proton pump inhibitors reduce the amount of acid that your stomach makes. Your doctor may prescribe Lansoprazole for the following conditions: - Treatment of duodenal and stomach ulcers - Treatment of inflammation in your oesophagus (reflux oesophagitis) - Prevention of reflux oesophagitis - Treatment of heartburn and acid regurgitation - Treatment of infections caused by the bacteria Helicobacter pylori when given in combination with antibiotic therapy - Treatment or prevention of duodenal or stomach ulcer in patients requiring continued NSAID treatment (NSAID treatment is used against pain or inflammation) - Treatment of Zollinger-El Прочетете целия документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lansoprazole 30 mg Gastro-resistant capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 30 mg of lansoprazole Excipients with known effect: Each 30 mg capsule contains sucrose For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gastro-resistant capsules _Product imported from the UK;_ Opaque, hard, white gastro-resistant capsule containing enteric-coated pellets. 4 CLINICAL PARTICULARS As per PA577/065/002 5 PHARMACOLOGICAL PROPERTIES As per PA577/065/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS maize starch sucrose sodium laurilsulphate meglumine mannitol (E421) hypromellose macrogol talc polysorbate titanium dioxide (E171) methacrylic acid-ethyl acrylate co-polymer capsule shell: gelatin titanium dioxide (E171) water 6.2 INCOMPATIBILITIES Not applicable HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 12/06/2015_ _CRN 2162254_ _page number: 1_ 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25ºC.Store in the original container in order to protect from moisture 6.5 NATURE AND CONTENTS OF CONTAINER Blister pack: 28 film-coated tablets in a cardboard box. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL Any unused product or waste material should be disposed of in accordance with local requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER WPR Healthcare Limited Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0565/057/002 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of fi Прочетете целия документ